Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Hyperparathyroidism, Secondary peptide trials
7 selected ClinicalTrials.gov records carrying the official condition label Hyperparathyroidism, Secondary. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
7 selected records.
1 profiles.
2017–2019 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 28 selected PubMed records and 1 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Hyperparathyroidism, Secondary unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT01134549
PeptideScanner retained ClinicalTrials.gov record NCT01134549 at 2026-11-15T22:07:29.454Z. Its registry update date was 2017-04-14, and PeptideScanner's reviewed identity mapping was etelcalcetide.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- April 14, 2017
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01134562
PeptideScanner retained ClinicalTrials.gov record NCT01134562 at 2026-11-15T22:07:29.454Z. Its registry update date was 2018-01-02, and PeptideScanner's reviewed identity mapping was etelcalcetide.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- January 2, 2018
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01785849
PeptideScanner retained ClinicalTrials.gov record NCT01785849 at 2026-11-15T22:07:29.454Z. Its registry update date was 2019-08-26, and PeptideScanner's reviewed identity mapping was etelcalcetide.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- August 26, 2019
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Etelcalcetide · 2019-08-26
ClinicalTrials.gov record NCT01785849
Completed at the retained observation.
Open attributed record →Etelcalcetide · 2019-08-20
ClinicalTrials.gov record NCT01788046
Completed at the retained observation.
Open attributed record →Etelcalcetide · 2019-04-10
ClinicalTrials.gov record NCT01785875
Completed at the retained observation.
Open attributed record →Etelcalcetide · 2018-10-17
ClinicalTrials.gov record NCT01932970
Completed at the retained observation.
Open attributed record →Etelcalcetide · 2018-01-02
ClinicalTrials.gov record NCT01134562
Completed at the retained observation.
Open attributed record →Etelcalcetide · 2017-11-17
ClinicalTrials.gov record NCT02102204
Completed at the retained observation.
Open attributed record →Etelcalcetide · 2017-04-14
ClinicalTrials.gov record NCT01134549
Completed at the retained observation.
Open attributed record →